Jordan Berlin, MD
Vanderbilt-Ingram Cancer Center · Vanderbilt University Medical Center · Vanderbilt University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jordan Berlin, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:20 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT03263429 · Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal CancerVanderbilt-Ingram Cancer Center · completed · Colorectal Cancer, Metastatic Colorectal Cancer, RAS Wild Type Colorectal Cancer · principal investigator
- Ph1/Ph2NCT02906670 · Sym013 (Pan-HER) in Patients With Advanced Epithelial MalignanciesSymphogen A/S · terminated · Oncology · principal investigator
- Ph2NCT02329717 · Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic AdenocarcinomaPhoenix Biotechnology, Inc · unknown · Pancreatic Cancer · principal investigator
- Ph2NCT01365910 · Linifanib in Treating Patients With Advanced, Refractory Colorectal CancerVanderbilt-Ingram Cancer Center · terminated · Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.